BEGIN:VCALENDAR VERSION:2.0 PRODID:-//wp-events-plugin.com//7.4.6//EN BEGIN:VEVENT UID:968@biocityturku.fi DTSTART;TZID=Europe/Helsinki:20261012T110000 DTEND;TZID=Europe/Helsinki:20261012T120000 DTSTAMP:20261005T100410Z URL:https://biocityturku.fi/events/inflames-seminar-13/ SUMMARY:InFLAMES Seminar: Ansel DESCRIPTION:12th October at 11:00-12:00\nOnsite event\nin Arje Sceinin audi torium\, Dentalia\n\nProfessor Mark Ansel\, University of California San F rancisco (UCSF)\, USA\nCellular and molecular regulation of Th2 inflammati on in the airways and other barrier tissues.\n\nHost: Riitta Lahesmaa (ril ahes@utu.fi).\n\nCoffee is served at 10:30.\n\nAfter his seminar\, Mark wi ll be available for lunch with early-career scientists at 12:30 in Bistro Elli\, Hotel Sokos Kupittaa. A registration is required. Register for the lunch here: https://link.webropol.com/s/ansel-lunch-2026.\n\nIf you want t o have a one-to-one discussion with Mark during his visit\, reserve a slot in his calendar at https://inflames.utu.fi/contact/reservation-calendars/ .\n\n \;\n\nProfessor Mark Ansel's research group at the University of California\, San Francisco\, studies the molecular regulation of immune r esponses that underlie the pathology of inflammatory diseases\, with a foc us on T cell programming and cytokine genes. They conduct fundamental rese arch on RNA regulation of the immune system. In addition\, they collaborat e closely with physician scientists\, technologists and data scientists to conduct mechanism-oriented human immunology research. Mark Ansel is a co- founder and current Chair of the UCSF Bakar ImmunoX Initiative and an acti ve affiliate of the Sandler Asthma Basic Research Center\, the Gladstone-U CSF Institute of Genomic Immunology and the UCSF Diabetes Center. ImmunoX and its UCSF Co-Labs provide access to technology platforms and domain exp erts using a novel collaborative structure and funding model that connects teams of scientists with clinical\, biological\, technological and comput ational expertise to maximize the impact of their research program in huma n immunology.\n\n \;\n\nSelected publications\n\nFassett MS\, Braz JM\ , Castellanos CA\, Salvatierra JJ\, Sadeghi M\, Yu X\, Schroeder AW\, Cast on J\, Munoz-Sandoval P\, Roy S\, Lazarevsky S\, Mar DJ\, Zhou CJ\, Shin J S\, Basbaum AI\, Ansel KM. IL-31-dependent neurogenic inflammation restrai ns cutaneous type 2 immune response in allergic dermatitis. Sci Immunol. 2 023 Oct 20\;8(88):eabi6887. doi: 10.1126/sciimmunol.abi6887. Epub 2023 Oct 13. PMID: 37831760\; PMCID: PMC10890830.\n\nSiddiqui S\, Johansson K\, Jo o A\, Bonser LR\, Koh KD\, Le Tonqueze O\, Bolourchi S\, Bautista RA\, Zlo ck L\, Roth TL\, Marson A\, Bhakta NR\, Ansel KM\, Finkbeiner WE\, Erle DJ \, Woodruff PG. Epithelial miR-141 regulates IL-13-induced airway mucus pr oduction. JCI Insight. 2021 Mar 8\;6(5):e139019. doi: 10.1172/jci.insight. 139019. PMID: 33682796\; PMCID: PMC8021117.\n\nWheeler BD\, Wang J\, Nerel la S\, Johansson K\, Garudadri S\, Muñoz-Sandoval P\, Mazumder T\, Christ enson SA\, Bhakta NR\, Erle DJ\, Ansel KM\, Woodruff PG. Allergen-responsi ve T helper type 2 cells revealed by high-dimensional profiling in allerge n challenged human airways. bioRxiv [Preprint]. 2026 Aug 6:2026.07.31.7417 82. doi: 10.64898/2026.07.31.741782. PMID: 42620144\; PMCID: PMC13484523. ATTACH;FMTTYPE=image/jpeg:https://biocityturku.fi/wp-content/uploads/2023/ 10/inflames-thumbnail.jpg CATEGORIES:Other events END:VEVENT BEGIN:VTIMEZONE TZID:Europe/Helsinki X-LIC-LOCATION:Europe/Helsinki BEGIN:DAYLIGHT DTSTART:20260329T040000 TZOFFSETFROM:+0200 TZOFFSETTO:+0300 TZNAME:EEST END:DAYLIGHT END:VTIMEZONE END:VCALENDAR